Pharmacokinetic Parameters

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pharmacokinetic Parameters trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 3

NCT06502990

Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy

This is an open-label, Phase 3b study to evaluate effectiveness, safety and pharmacokinetic parameters of metreleptin in patients under 6 years of age with gene…

Belgium, France, Germany15 participantsStarted 2025-05-23

Treatment: Metreleptin

RecruitingNot Applicable

NCT07346716

Medicines in Breast Milk and Estimated Infant Exposure

The MedMilk (Medication concentrations in human Milk) study investigates how selected medicines taken by breastfeeding women are transferred into human milk and…

Denmark250 participantsStarted 2024-12-20

Treatment: Prescription Drugs

All recent trials (100 shown)

CompletedPhase 2

NCT06391593

PD, PK, and Safety of ALTO-203 in Patients With MDD

The goal of this clinical trial is to determine the pharmacodynamic effects of ALTO-203 in patients with MDD in a randomized, placebo-controlled, single-dose cr…

United States69 participantsStarted 2024-03-25

Treatment: ALTO-203 25 μg, ALTO-203 75 μg

CompletedPhase 2

NCT00528060

Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once D…

the trial assessed the pharmacokinetics and long term plasma exposure of the following antiretrovirals: atazanavir when combined to ritonavir and the tenofovir/…

France35 participantsStarted 2008-01

Treatment: Atazanavir, Ritonavir

Pharmacokinetic Parameters

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy

Medicines in Breast Milk and Estimated Infant Exposure

All recent trials (100 shown)

PD, PK, and Safety of ALTO-203 in Patients With MDD

Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once D…

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy

Medicines in Breast Milk and Estimated Infant Exposure

All recent trials (100 shown)

PD, PK, and Safety of ALTO-203 in Patients With MDD

Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once D…

TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL)

A Clinical Trial to Assess the Pharmacokinetic Profile of Three Coenzyme Q10 Formulations in Healthy Adults

Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Function

Pharmacokinetic Study of Rezafungin in Patients With Suspected Intra-Abdominal Candidiasis

Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)

Pharmacokinetic/Pharmacodynamic Parameters of NNG-DEPO (Stimus) With Aranesp® (Amgen) in Treatment of Anemia in CKD Pati…

Study to Evaluate LPH-5 in Healthy Subjects

Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence.

VLT-015 in Patients With Schizophrenia

The Microalga Phaeodactylum Tricornutum a Potential Fish Substitute?- Pharmacokinetic Study

Population Pharmacokinetic Study of the Effect of Polymorphisms in the ABCB1 and CES1 Genes on the Pharmacokinetics of D…

Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women

Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.

Safety, Tolerability and Pharmacokinetics of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Multiple Oral…

Study Assessing Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MGTA-145 in Healthy Volunteers as a Sing…

A Study to Evaluate Pharmacokinetic Parameters of Eliglustat in Healthy Volunteers Who Are CYP2D6 Extensive or Poor Meta…

A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth

rFVIII-Fc (Produced by AryoGen Pharmed Co.) Pharmacokinetic Study